MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1878313
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
MAIA Bio filed an 8-K, standard stuff, check exhibits for details.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on March 28, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates MAIA Biotechnology, Inc. is meeting its regulatory reporting obligations. Investors should review the exhibits for any specific disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- March 28, 2025 (date) — Date of Report
- Regulation FD Disclosure (disclosure) — Item Information
- Financial Statements and Exhibits (document) — Item Information
- 001-41455 (file_number) — SEC File Number
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure as an item of report, but the specific content of this disclosure is not detailed within the provided text and would be found in the accompanying exhibits.
What types of financial statements and exhibits are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item of report. The specific nature and content of these documents are not detailed in the provided text and would be available in the full filing.
When was this 8-K report filed?
This 8-K report was filed on March 28, 2025.
What is the principal executive office address for MAIA Biotechnology, Inc.?
The address of the principal executive offices for MAIA Biotechnology, Inc. is 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the SEC file number for MAIA Biotechnology, Inc.?
The SEC file number for MAIA Biotechnology, Inc. is 001-41455.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding MAIA Biotechnology, Inc. (MAIA).